Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000178848 | SCV000231013 | uncertain significance | not provided | 2014-07-20 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV002515270 | SCV002985823 | uncertain significance | Bethlem myopathy 1A | 2022-02-19 | criteria provided, single submitter | clinical testing | This variant has not been reported in the literature in individuals affected with COL6A1-related conditions. ClinVar contains an entry for this variant (Variation ID: 197730). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. This variant is present in population databases (rs775349013, gnomAD 0.01%). This sequence change affects codon 239 of the COL6A1 mRNA. It is a 'silent' change, meaning that it does not change the encoded amino acid sequence of the COL6A1 protein. It affects a nucleotide within the consensus splice site. |
Ce |
RCV000178848 | SCV004701125 | likely benign | not provided | 2024-02-01 | criteria provided, single submitter | clinical testing | COL6A1: BP4, BP7 |